
KLOW is a blended multi-peptide research formulation: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV (80mg total per vial). Combines GHK-Cu's collagen/wound-healing signaling with BPC-157 and TB-500's tissue-repair and angiogenesis research profiles, plus KPV's anti-inflammatory research profile.
Certificate of Analysis for this listing is available from the supplier. View all COAs →